FDA warns of toxic compound exposure in hemodialysis machines 

The FDA issued a notification May 10 about the potential risk of exposure to toxic compounds in Fresenius Medical Care hemodialysis machines.

Advertisement

The compounds are non-dioxin-like polychlorinated biphenyl acids and polychlorinated biphenyls. They can be found in silicone tubing used in the hydraulics in the machine and the dialysate lines. Although it does not directly contact the blood, there is a potential for back-filtering through the dialyzer into the patient’s blood during treatment. 

The agency has not received any reports of adverse events related to the machines and is working with the manufacturer to further collect and evaluate data to determine exposure risk.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.